CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
These non-invasive tests analyse the foetal DNA in your blood to identify whether your baby could have any chromosomal conditions, including Down’s syndrome, Edwards’ syndrome and Patau’s syndrome.
We use the Illumina VeriSeq NIPT Solution v2. The test is safe, accurate, and has a high detection rate for these three conditions.